Neonatal abstinence syndrome and early childhood morbidity and mortality in Washington state: a retrospective cohort study

被引:47
作者
Witt, C. E. [1 ,2 ,3 ]
Rudd, K. E. [1 ,4 ]
Bhatraju, P. [1 ,4 ]
Rivara, F. P. [1 ,2 ,5 ]
Hawes, S. E. [1 ]
Weiss, N. S. [1 ]
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[2] Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359960, Seattle, WA 98104 USA
[3] Univ Washington, Dept Surg, Seattle, WA 98195 USA
[4] Univ Washington, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[5] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
关键词
WITHDRAWAL SYNDROME; DEPENDENT MOTHERS; OPIOID USE; EXPOSURE; METHADONE; INFANTS; BUPRENORPHINE; OUTCOMES; PREVALENCE; MANAGEMENT;
D O I
10.1038/jp.2017.106
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The objective of the study was to evaluate the association between neonatal abstinence syndrome (NAS) and long-term childhood morbidity and infant mortality. STUDY DESIGN: We conducted a cohort study of infants born in Washington State during 1990 to 2008 who were diagnosed with NAS (n = 1900) or were unexposed (n = 12,283, frequency matched by birth year). 5-year hospital readmissions and infant mortality were ascertained. RESULTS: Children with history of NAS had increased risk of readmission during the first 5 years of life relative to unexposed children; this remained statistically significant after adjustment for maternal age, maternal education, gestational age and intrapartum smoking status (readmission rates: NAS = 21.3%, unexposed = 12.7%, adjusted relative risk (aRR) 1.54, 95% confidence interval (CI) 1.37 to 1.73). NAS was associated with increased unadjusted infant mortality risk, but this did not persist after adjustment (aRR 1.94, 95% CI 0.99 to 3.80). CONCLUSION: The observed increased risk for childhood hospital readmission following NAS diagnosis argues for development of early childhood interventions to prevent morbidity.
引用
收藏
页码:1124 / 1129
页数:6
相关论文
共 34 条
  • [1] Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants
    Allocco, Elizabeth
    Melker, Marjorie
    Rojas-Miguez, Florencia
    Bradley, Caitlin
    Hahn, Kristen A.
    Wachman, Elisha M.
    [J]. ADVANCES IN NEONATAL CARE, 2016, 16 (05) : 329 - 336
  • [2] Consequences of prenatal opioid use for newborns
    Anand, Kanwaljeet J. S.
    Campbell-Yeo, Marsha
    [J]. ACTA PAEDIATRICA, 2015, 104 (11) : 1066 - 1069
  • [3] [Anonymous], 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002059
  • [4] Prenatal Drug Exposure: Infant and Toddler Outcomes
    Bandstra, Emmalee S.
    Morrow, Connie E.
    Mansoor, Elana
    Accornero, Veronica H.
    [J]. JOURNAL OF ADDICTIVE DISEASES, 2010, 29 (02) : 245 - 258
  • [5] Identification of Early Developmental Deficits in Infants With Prenatal Heroin, Methadone, and Other Opioid Exposure
    Beckwith, Anna Malia
    Burke, Sharon A.
    [J]. CLINICAL PEDIATRICS, 2015, 54 (04) : 328 - 335
  • [6] Using population data to examine the prevalence and correlates of neonatal abstinence syndrome
    Burns, Lucy
    Mattick, Richard P.
    [J]. DRUG AND ALCOHOL REVIEW, 2007, 26 (05) : 487 - 492
  • [7] Methadone and perinatal outcomes: a retrospective cohort study
    Cleary, Brian J.
    Donnelly, Jean M.
    Strawbridge, Judith D.
    Gallagher, Paul J.
    Fahey, Tom
    White, Martin J.
    Murphy, Deirdre J.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (02) : 139.e1 - 139.e9
  • [8] Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada
    Davies, Hilary
    Gilbert, Ruth
    Johnson, Kathryn
    Petersen, Irene
    Nazareth, Irwin
    O'Donnell, Melissa
    Guttmann, Astrid
    Gonzalez-Izquierdo, Arturo
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2016, 101 (01): : 26 - 30
  • [9] Prenatal Oxycodone Exposure Alters CNS Endothelin Receptor Expression in Neonatal Rats
    Devarapalli, M.
    Leonard, M.
    Briyal, S.
    Stefanov, G.
    Puppala, B. L.
    Schweig, L.
    Gulati, A.
    [J]. DRUG RESEARCH, 2016, 66 (05) : 246 - 250
  • [10] FINNEGAN LP, 1975, ADDICT DIS, V2, P141